Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
36.60
+0.47 (1.30%)
At close: Sep 4, 2026, 4:00 PM EDT
36.78
+0.18 (0.49%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Assembly Biosciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Assembly Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $52. The average 1-year stock price forecast is 42.08% higher than the current stock price, while the lowest is $43 (+17.49%) and the highest is $62 (+69.40%).

Price Target: $52 (+42.08%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$43$52$52$62
Change+17.49%+42.08%+42.08%+69.40%

Analyst Ratings

The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Aug '26Sep '26
Strong Buy444445
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total444445

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Buy
Initiates
$52
BuyInitiates$52+42.08%Sep 1, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$45$53
BuyMaintains$45$53+44.81%Aug 31, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$50
BuyReiterates$50+36.61%Aug 18, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$43
BuyReiterates$43+17.49%Aug 17, 2026

Financial Forecast

Revenue This Year
63.43M
from 72.30M
Decreased by -12.27%
Revenue Next Year
34.40M
from 63.43M
Decreased by -45.77%
EPS This Year
-0.12
from -0.55
EPS Next Year
-2.59
from -0.12
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.25M-7.16M28.52M72.30M63.43M
Revenue Growth
-92.09%--298.16%153.52%-12.27%
Operating Income
-92.40M-93.01M-64.65M-45.42M-12.12M-21.37M
Net Income
-129.86M-93.09M-61.23M-40.18M-6.12M1.40M
EPS
-----0.55-0.12
Free Cash Flow
-62.75M-48.91M-8.20M-15.71M-4.98M9.60M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High112.9M
Avg63.4M
Low22.0M

Revenue Growth

Revenue Growth202620272028
High
56.1%
Avg
-12.3%
Low
-69.6%

EPS Forecast

EPS202620272028
High2.28
Avg-0.12
Low-2.86

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-